Abstract
The elevated methionine (MET) requirement for the growth of tumors, first observed by Sugimura in 1959, termed MET dependence, is a potentially highly effective therapeutic target. Proof of this principle is that when MET restriction (MR) was initially established in co-cultures of cancer and normal cells, MET dependence could be exploited to selectively kill cancer cells without killing co-cultured normal cells. MET-dependent cells become reversibly blocked in the late S/G2 phase of the cell cycle under MR enabling selective and effective S-phase chemotherapy against these blocked cancer cells. Subsequent MET repletion with an anti-mitotic drug was totally effective at selectively eliminating the MET-dependent cancer cells enabling the normal MET-dependent cells to take over the culture. We have also observed that the MET analog ethionine (ETH) is synergistic with MR in arresting the growth of the Yoshida sarcoma both in vitro and eliminating metastasis when transplanted to nude mice. MR increased the efficacy of cisplatinum (CDDP) against the MX-1 human breast carcinoma cell line when grown in nude mice. MR increased 5-fluorouracil (5-FU) efficacy on a human gastric cancer xenograft, SC-1-NU, in nude mice. MET-restricted total parenteral nutrition (MR TPN) was effective in Yoshida sarcoma-bearing rats. MR TPN with doxorubicin (DOX) and vincristine (VCR) resulted in significant tumor suppression and prolonged survival of Yoshida-sarcoma-bearing rats. These results were the basis of subsequent studies that used methioninase to effect MR for effective cancer therapy.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hoffman RM (2015) Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40 year odyssey. Expert Opin Biol Ther 15:21–31
Hoffman RM (1984) Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. Biochim Biophys Acta 738:49–87
Hoffman RM (1985) Altered methionine metabolism and transmethylation in cancer. Anticancer Res 5:1–30
Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM (1983) The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 117:429–434
Duvigneaud V, Dyer HM, Harmon J (1935) The growth-promoting properties of homocysteine when added to cysteine-deficient diet and the proof of structure of homocysteine. J Biol Chem 101:719–726
Hoffman RM, Jacobsen SJ (1980) Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci U S A 77:7306–7310
Stern PH, Hoffman RM (1986) Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 76:629–639
Breillout F, Hadida F, Echinard-Darin P, Lascaux V, Poupon MF (1987) Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet. Anticancer Res 7:861–867
Breillout F, Antome E, Poupon MF (1990) Methionine dependency of malignant tumors: a possible approach for therapy. J Natl Cancer Inst 82:1628–1632
Goseki N, Yamazaki S, Endo M (1992) Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats. Cancer 69:1865–1872
Yoshida S, Yamasaki K, Kaibara A, Takagi K, Noake T, Ishibashi N, Kakegawa T (1995) Effect of methionine-deprived total parenteral nutrition on tumor protein turnover in rats. Cancer 76:1275–1282
Guo H, Tan Y, Kubota T, Moossa AR, Hoffman RM (1996) Methionine depletion modulates the antitumor and antimetastatic efficacy of ethionine. Anticancer Res 16:2719–2723
Guo H, Lishko VK, Herrera H, Kubota T, Hoffman RM (1993) Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res 53:5676–5679
Nagahama T, Goseki N, Endo M (1998) Doxorubicin and vincristine with methionine depletion contributed to survival in the Yoshida sarcoma bearing rats. Anticancer Res 18:25–32
Hoshiya T, Kubota T, Inada T, Kitajima M, Hoffman RM (1997) Methionine-depletion modulates the efficacy of 5-fluorouracil in human gastric cancer in nude mice. Anticancer Res 17:4371–4376
Hoffman RM, Jacobsen SJ, Erbe RW (1978) Reversion to methionine independence by malignant rat and SV40-transformed human fibroblasts. Biochem Biophys Res Commun 82:228–234
Kaighn M, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostate carcinoma cell line (PC-3). Invest Urol 17:16–25
Ovejera AA, Houchens DP, Barker AD (1978) Chemotherapy of human tumor xenografts in genetically athymic mice. Ann Clin Lab Sci 8:50–56
Hoshiya Y, Kubota T, Matsuzaki SW, Kitajima M, Hoffman RM (1996) Methionine starvation modulates the efficacy of cisplatin on human breast cancer in nude mice. Anticancer Res 16:3515–3517
Coalson DW, Mecham JO, Stern PH, Hoffman RM (1982) Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells. Proc Natl Acad Sci U S A 79:4248–4251
Leroy AF, Wehling MI, Sponseller HL, Friauf WS, Solomon RE, Dedrick RL, Litterst CL, Gram TE, Guarino AM, Becker DA (1977) Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 18:184–191
Goseki N, Yamazaki S, Shimojyu K, Kando F, Maruyama M, Endo M, Koike M, Takahashi H (1995) Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial. Jpn J Cancer Res 86:484–489
Goseki N, Endo M, Onodera T, Kosaki G (1991) Anti-tumor effect of L-methionine-deprived total parenteral nutrition with 5-fluourouracil administration on Yoshida sarcoma-bearing rats. Ann Surg 213:83–88
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Hoffman, R.M., Stern, P.H. (2019). Dietary Methionine Restriction-Based Cancer Chemotherapy in Rodents. In: Hoffman, R. (eds) Methionine Dependence of Cancer and Aging. Methods in Molecular Biology, vol 1866. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8796-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8796-2_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8795-5
Online ISBN: 978-1-4939-8796-2
eBook Packages: Springer Protocols